When we monitored NFE2L1 and NDUFA9 protein levels using six paired HCC and adjacent tissue samples, four cases showed clearly increased NFE2L1 expression in tumor compared to the surrounding tissue. This evidence concerns the gene NDUFA9 and hepatocellular carcinoma.